· Theory
· Determinants
· Application
Definition |
· The volume into which a substance appears to be dispersed based on relationship between dose and plasma concentration · Not a physical volume · Can be larger than total body volume |
Subtypes |
· Body is not homogenous · Drugs given or absorbed into plasma, then distributed · Require multicompartmental modelling · Central VD: prior to distribution (e.g. propofol 0.3-0.6L/kg) · Steady state VD: after distribution (e.g. propofol 4L/kg) |
Location |
· <40mL/kg: plasma (e.g. warfarin) · <200mL/kg: ECF (e.g. rocuronium) · <600mL/kg: TBW · >600mL/kg: fat (e.g. propofol) or tissue protein-bound (e.g. amiodarone) |
Drug |
↑VD: · Small (e.g. propofol) · Non-polar, lipophilic (e.g. fentanyl) · Tissue protein binding (e.g. amiodarone 70L/kg) ↓VD: · Large (e.g. suxamethonium) · Polar, hydrophilic (e.g. suxamethonium) · Plasma protein-bound (e.g. warfarin 0.1L/kg) |
Physiology |
· Neonate: ↑total body water, ↑VD water soluble drugs · Pregnant: ↑muscle, ↑adipose, ↑water; ↑VD most drugs · Elderly: ↓muscle, ↓water, ↑%adipose: ↓VD water soluble drugs |
Pathology |
· Fluid overload (heart/liver/kidney failure): ↑VD water soluble drugs · ↓Plasma proteins (e.g. liver failure): ↑VD highly plasma protein bound drugs · If low hepatic extraction ratio: ↑↑Free drug -> ↑↑effect (e.g. phenytoin) · Dehydration: ↓VDC most drugs (e.g. propofol), ↓VDSS water-soluble drugs |
Measurement |
· Administer known amount of drug · Measure subsequent plasma concentration · VD = n / C (where ‘n’ is the total bioavailable amount) |
Equations |
·
VD = amount of drug / measured
concentration · VD = clearance / rate constant |
Assumptions |
· Single compartment · 100% bioavailability · Equilibration complete · No metabolism or excretion prior to blood sampling |
Use |
· Calculate loading dose (e.g. amiodarone) · Predict offset after drug infusion (e.g. propofol TCI models) |
Feedback welcome at ketaminenightmares@gmail.com